Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa, Yi Mu, Wendy Bamberg et al. · New England Journal of Medicine · 2015
BACKGROUND: The magnitude and scope of Clostridium difficile infection in the United States continue to evolve. METHODS: In 2011, we performed active population- and laboratory-based surveillance across 10 geographic areas in the United States to identify cases of C. difficile infection (stool specimens positive for C. difficile on either toxin or molecular assay in residents ≥ 1 year of age). Cases were classified as community-associated or health care-associated. In a sample of cases of C. difficile infection, specimens were cultured and isolates underwent molecular typing. We used regression models to calculate estimates of national incidence and total number of infections, first recurrences, and deaths within 30 days after the diagnosis of C. difficile infection. RESULTS: A total of 15,461 cases of C. difficile infection were identified in the 10 geographic areas; 65.8% were health care-associated, but only 24.2% had onset during hospitalization. After adjustment for predictors of disease incidence, the estimated number of incident C. difficile infections in the United States was 453,000 (95% confidence interval [CI], 397,100 to 508,500). The incidence was estimated to be higher among females (rate ratio, 1.26; 95% CI, 1.25 to 1.27), whites (rate ratio, 1.72; 95% CI, 1.56 to 2.0), and persons 65 years of age or older (rate ratio, 8.65; 95% CI, 8.16 to 9.31). The estimated number of first recurrences of C. difficile infection was 83,000 (95% CI, 57,000 to 108,900), and the estimated number of deaths was 29,300 (95% CI, 16,500 to 42,100). The North American pulsed-field gel electrophoresis type 1 (NAP1) strain was more prevalent among health care-associated infections than among community-associated infections (30.7% vs. 18.8%, P<0.001). CONCLUSIONS: C. difficile was responsible for almost half a million infections and was associated with approximately 29,000 deaths in 2011. (Funded by the Centers for Disease Control and Prevention.).
Cited by 2,585 works. doi:10.1056/nejmoa1408913 Open-access PDF
Authors
- Fernanda C. Lessa
- Yi Mu
- Wendy Bamberg
- Zintars G. Beldavs
- Ghinwa K. Dumyati
- John R. Dunn
- Monica M. Farley
- Stacy Holzbauer
- James I. Meek
- Erin C. Phipps
- Lucy E Wilson
- Lisa Gail Winston
- Brandi M. Limbago
- Scott K. Fridkin
- Dale N. Gerding
- L. Clifford McDonald
References
- Sampling: Design and Analysis
- An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
- A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
- Multistate Point-Prevalence Survey of Health Care–Associated Infections
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations
- Multiple Imputation for the Fatal Accident Reporting System
- Antimicrobial Agents and Clostridium difficile in Acute Enteric Disease: Epidemiological Data from Sweden, 1980-1982
- Clostridium difficile infection in Europe: a hospital-based survey
- Treatment with Monoclonal Antibodies against Clostridium difficile Toxins